Karran Phillips, M.D., M.Sc.

Senior Clinician

Treatment Section (The Archway Clinic)

NIDA

Clinical Director

NIDA

Biomedical Research Center
251 Bayview Boulevard
Suite 200, Room 02A638
Baltimore, MD 21224

443-740-2360

phillipsk@nida.nih.gov

Research Topics

The Office of the Clinical Director (OCD) coordinates, supports, and supervises the development, implementation and conduct of intramural clinical research activities. The OCD provides the infrastructure needed to promote top quality clinical research and to ensure research participant safety and confidentiality. This infrastructure includes a research participant recruitment and screening center, a 45-slot addiction treatment outpatient research clinic and multiple specialized study rooms (including smoking chambers, mock MRI scanner, and physiological monitoring). In addition, a digital medical record system on a secure network has been developed and allows for all research related data to be accessible from within the IRP.

Selected Publications

  1. Hertzel SK, Schroeder J, Moran LM, Alvanzo AA, Kowalczyk WJ, Epstein DH, Preston KL, Phillips KA. Perceptions of Neighborhood Mediate the Relationship Between PTSD Symptoms and Coping in a Neighborhood-Matched Substance-Using Sample. J Addict Med. 2017;11(6):440-448.

  2. Kowalczyk WJ, Phillips KA, Jobes ML, Kennedy AP, Ghitza UE, Agage DA, Schmittner JP, Epstein DH, Preston KL. Clonidine Maintenance Prolongs Opioid Abstinence and Decouples Stress From Craving in Daily Life: A Randomized Controlled Trial With Ecological Momentary Assessment. Am J Psychiatry. 2015;172(8):760-7.

  3. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014;87:150-60.

  4. Stull SW, Panlilio LV, Moran LM, Schroeder JR, Bertz JW, Epstein DH, Preston KL, Phillips KA. The chippers, the quitters, and the highly symptomatic: A 12-month longitudinal study of DSM-5 opioid- and cocaine-use problems in a community sample. Addict Behav. 2019;96:183-191.


This page was last updated on November 2nd, 2018